• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Blogs » BioWorld MedTech Perspectives » When technology fails - and trust me, it will

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

When technology fails - and trust me, it will

Jan. 23, 2012
By Amanda Pedersen
Message_pad_with_pen
Whatever happened to the old-school message system?

Nearly every day at MDD we report on the latest advances in health IT, one of the fastest growing sectors in the industry.  It seems like new HIT and systems-related companies are cropping up every week, promising to enhance communication between patients and providers, and improve clinical workflow.

But what happens when this technology fails – and trust me, it will – and the people trained to use these fancy pants systems are not taught how to go back to the basics, a.k.a. the pen-and-paper method?

Let me give you an example from my own recent experience with the military’s healthcare system, which I believe is a perfect example of a system that heavily relies on the aforementioned fancy pants communications/workflow systems.

Tuesday I needed to leave a message for my primary care provider. The reason for my message in the first place was frustrating - I needed to tell her that she had either not read or not adequately understood the notes of the hospital's gastroenterologist when he recently declined her referral to send me to him. You see, the GI doctor actually had a good reason for refusing to see me - he took the time to read my history and determined that I would be better off seeing a GI surgeon than himself (I've had a total colectomy and now have what is called a J-pouch where my surgeon fashioned my small intestines into the shape of a J where my colon used to be). But instead of actually reading his notes herself and referring me to a surgeon, the primary doc instead relayed a message to me that my referral had been declined and that if I still felt the need to see a GI I should go to the emergency room.

Knowing that this was an absolutely absurd recommendation as I clearly need to be able to see a specialist regarding my condition, my next step was to contact the referral management office located in the same military hospital as both doctors involved.

The referral management person I spoke with read all of the notes from both doctors and recommended that I leave a message for the first doctor to either speak with the GI directly or at least read his notes completely so that she can see for herself that he was actually suggesting I be referred to a surgeon.

So what happened when I called the clinic to leave a message for the first doctor? I was told by a receptionist that “the system to leave a message is down so you’ll have to keep calling back until it’s back up again.” Hey, here’s an innovative idea: get a piece of paper and a pen and WRITE my message down.

Four calls and 24 hours later the system was finally back up and I was able to leave the message. I'm still waiting for someone to call me back with her response. Why do I get the feeling that I'll be updating this blog next week to say that I'm still waiting for that call? I hope I'm wrong about that though.

I get that technology fails at times. Anyone who has ever used any kind of technology for any length of time knows that it happens. But what about a back-up plan so that patients don’t have to pay the price of a system that fails to teach its staff the basics of taking a phone message? Would it really have been so difficult for the receptionist to take a message the old-school way and deliver it to the doctor who is in the very same office?

Popular Stories

  • Telomeres and DNA illustration

    23andme founder-led group outbids Regeneron for company

    BioWorld
    The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2025.
  • Sarepta signage

    Elevidys’ second liver death hits Sarepta, sends DMD ripples

    BioWorld
    How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 17, 2025.
  • 3D representation of tumor microenvironment

    EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

    BioWorld Science
    Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe